BIIB - Company ID 0000875045
BIOGEN INC. (BIIB) reported revenue of $9.89B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $9.89B | +2.2% |
| FY 2024 | $9.68B | -1.6% |
| FY 2023 | $9.84B | -3.3% |
| FY 2022 | $10.17B | -7.4% |
| FY 2021 | $10.98B | -18.3% |
| FY 2020 | $13.44B | -6.5% |
| FY 2019 | $14.38B | +6.9% |
| FY 2018 | $13.45B | +9.6% |
| FY 2017 |
BIOGEN INC. (BIIB) reported revenue of $9.89B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, BIOGEN INC.'s revenue grew from $5.05B to $9.89B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $12.27B |
| +7.2% |
| FY 2016 | $11.45B | +6.4% |
| FY 2015 | $10.76B | +10.9% |
| FY 2014 | $9.70B | +40.0% |
| FY 2013 | $6.93B | +25.7% |
| FY 2012 | $5.52B | +9.3% |
| FY 2011 | $5.05B | - |